US FDA panel will advise on communicating risks

(Reuters) - The new advisory committee "will bring together a broad
range of experts and views to help improve FDA's communication
of the science-based information about product risks and
benefits that the public needs to make informed decisions,"
Randall Lutter, FDA's acting deputy commissioner for policy,
said in a statement.




Fifteen voting members will sit on the panel. The FDA said
they would include experts on risk communication, social
marketing, health literacy, journalism, bioethics and other
relevant fields.


Read more at Reuters.com Government Filings News